The results of numerous high-impact phase 3 clinical trials that could affect kidney-related medical care will be presented ...

Paper highlights Zabalafin Hydrogel's potential as a single topical atopic dermatitis therapy that impacts the Staphylococc ...

Rough skin on the feet is a common condition can occur for a variety of reasons - but one doctor has explained why some ...

Mirum Pharmaceuticals to Showcase LIVMARLI Data from its ALGS and PFIC Programs at the NASPGHAN Annual Meeting ...

When people think about kidney disease, they often focus on its role in filtering blood, managing fluid levels, and balancing ...

Tharimmune (THAR) received feedback from a Scientific Advice meeting with the European Medicines Agency that included guidance on a planned ...

Tharimmune, Inc. (NASDAQ:THAR) shares are moving higher on Wednesday after the company announced it received overall positive ...

Big news out of New Jersey this morning as a %Biotech company said it received “positive feedback” from the European ...

Nighttime itch can be annoying and even worrying. Here, 5 possible reasons you're itchy at night, as well as ...

Shares of Tharimmune Inc. shot up more than 100% in early trading Oct. 30 as the firm disclosed regulatory backing to launch a phase II trial this quarter testing TH-104, a transdermal buccal film ...

Targeting the kappa opioid receptor with an agonist is a new pharmacy strategy for treating moderate to severe CKD-associated ...